Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 3,851 |
|
|||||
| News | - | ||||||
| Day High | 1.59 | Low High |
|||||
| Day Low | 1.50 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cocrystal Pharma Inc | COCP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0061 | -0.39% | 1.5559 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.59 | 1.50 | 1.59 | 1.5559 | 1.562 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 52 | 3,851 | $ 1.54 | $ 5,929 | - | 1.325 - 3.285 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:49:39 | 1 | $ 1.50 | USD |
Cocrystal Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 15.87M | 10.17M | - | 2.6M | -17.98M | -1.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cocrystal Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COCP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.43 | 1.5999 | 1.4196 | 1.50 | 6,299 | 0.1259 | 8.80% |
| 1 Month | 1.48 | 1.74 | 1.35 | 1.48 | 18,711 | 0.0759 | 5.13% |
| 3 Months | 1.60 | 1.74 | 1.325 | 1.49 | 13,942 | -0.0441 | -2.76% |
| 6 Months | 1.62 | 1.99 | 1.325 | 1.63 | 16,281 | -0.0641 | -3.96% |
| 1 Year | 2.49 | 3.285 | 1.325 | 2.20 | 23,308 | -0.9341 | -37.51% |
| 3 Years | 15.36 | 41.52 | 1.325 | 19.16 | 1,834,082 | -13.80 | -89.87% |
| 5 Years | 30.60 | 49.20 | 1.325 | 18.86 | 2,049,295 | -29.04 | -94.92% |
Cocrystal Pharma Description
| Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). |
